Skip to main content
Home
  • About Us
  • Science
  • Investors
    Investors
    • Reports and Presentations
    • Share price Information
    • Governance
    • Shareholders' Meeting
    • FAQs
    • Email Alerts
    Investors

    Keep track of our business - This area contains investment and shareholder information

  • News and Events
    News and Events
    • Events
    • News
    • Adhoc news
    News and Events

    We provide regular updates on the progress being made.

  • Contacts
    Contacts
    • Work with us
    Contacts

    Newron is located in the north part of Milan in the new Bresso Bioscience Park about 45 minutes from Malpensa International Airport and 25/30 minutes from Linate city airport.

  • SearchSearch
    Search
Content Date
Oct 11 2025
Result Year
2025
Link Document Content
Evenamide Phase 3 Program: Study 023 (ENIGMA-TRS 1) evaluates the efficacy of add-on glutamate modulation in patients with documented treatment-resistant schizophrenia
Quick Links
  • About Us
  • Science
  • Investors
  • News and Media
  • Contacts
  • Cookie Policy
  • Cookie Settings

Contact

Newron Pharmaceuticals SpA
via Antonio Meucci 3
20091 Bresso (Mi) Italy
Tel +39 02 610 3461
E-mail: [email protected]

More contacts

𝐖𝐡𝐢𝐬𝐭𝐥𝐞𝐛𝐥𝐨𝐰𝐢𝐧𝐠

Annual Report 2023

Download PDF

Stay in touch

Keep up to date on social media

Footer
  • Disclaimer
  • Privacy
  • Privacy notice
  • ©2026 - Newron Pharmaceuticals SPA. All Rights Reserved
  • Company Registration Number (VAT and Tax Code): 02479490126 (Milan)
  • Share Capital: EUR 3.726.366,80
  • Sitemap